Skip to main content
Journal of Toxicologic Pathology logoLink to Journal of Toxicologic Pathology
. 2018 Feb 2;31(2):95–103. doi: 10.1293/tox.2017-0056

Morphological and immunohistochemical diversity of endometrial stromal sarcoma in rats

Shino Kumabe 1, Junko Sato 1,*, Yuki Tomonari 1, Miwa Takahashi 2, Kaoru Inoue 3, Midori Yoshida 3, Takuya Doi 1, Yumi Wako 1, Minoru Tsuchitani 1
PMCID: PMC5938210  PMID: 29749998

Abstract

To clarify the histopathological characteristics of rat endometrial stromal sarcoma (ESS), we morphologically reviewed 12 malignant uterine tumors protruding into the lumen in previous rat carcinogenicity studies. The 12 cases were classified into the following 6 types based on their morphological features: spindle cell and collagen rich type, pleomorphic/spindle cell and compact type, decidual alteration type, histiocytic and multinucleated giant cell mixture type, Antoni A-type schwannoma type, and Antoni B-type schwannoma type. Immunohistochemically, tumor cells in all cases exhibited focal or diffuse positive reactions for vimentin, and 11 of the 12 cases were positive for S-100. Interestingly, 9 cases were positive for desmin or αSMA, indicating tumor cells expressing smooth muscle properties. Both Antoni A- and B-type schwannoma types showed low reactions for both muscle markers. Positive results for estrogen receptor α in the 11 cases suggested that they were derived from endometrial stromal cells. On the basis of their immunohistochemical profiles, they were considered to be derived from endometrial stromal cells while they showed morphological variation. The detection of a basement membrane surrounding tumor cells might not be a definitive indicator for differential diagnosis of ESS from malignant schwannoma. In conclusion, ESS could exhibit wide morphological and immunohistochemical variation including features of schwannoma or smooth muscle tumor.

Keywords: endometrial stromal sarcoma, rat, S-100, ERα, immunohistochemistry

Introduction

Tumors protruding from the endometrium into the uterus lumen are frequently observed in aging rats. Although the majority of these tumors are benign endometrial stromal polyps derived from endometrial stromal cells, a small proportion are malignant tumors known as endometrial stromal sarcomas (ESSs). Tumors diagnosed as ESS are histologically varied and are predominantly composed of spindle cells arranged in loose sheets, in interlacing fasciculi, or, in rare cases, pleomorphic polygonal cells arranged in solid sheets. In some cases, multinucleated giant cells or decidual reactions are observed within tumors1, 2, 3, 4, 5.

Uterine sarcomas aside from ESS have also been identified, such as leiomyosarcoma and malignant schwannoma1, 2, 4, 5, 6. The Hematoxylin and eosin (HE) staining-based morphological distinction of ESS from leiomyosarcoma or malignant schwannoma is often difficult due to wide histological variation and partly similarity to other sarcoma in ESS. Immunochemical staining or electron microscopic analysis have been accepted as useful tools for differential diagnosis of ESS from other uterine sarcomas1, 2, 4, 5. Both ESS and malignant schwannoma are immunochemically positive for vimentin and S-100, and the presence of a basement membrane is evidence of schwannoma alone2, 5. On the other hand, in routine pathological examination in carcinogenicity studies, immunohistochemical or electron microscopic analysis for definition of each uterine malignant tumor has been rarely performed due to the substantial amount of labor and time required for these analyses. Therefore, the mechanisms behind the various histological features of ESS remain unclear.

The Histological features of human ESS also vary. A number of studies on differential diagnosis have been performed, particularly to distinguish ESS from uterine smooth muscle tumors. Recently, CD10 has been identified as an effective marker of ESS in humans7, 8, 9, 10, 11. Given that CD10 was originally observed on the cell surface of acute lymphoblastic leukemia7, 12, 13, this marker is also known as common acute lymphoblastic leukemia antigen (CALLA) and has additionally been observed on normal human endometrial stromal cells and human ESS8, 9. CD10 has also been characterized and investigated as another hormone-related antigen, such as the estrogen receptor (ER), progesterone receptor, and inhibin α, with utility as an ESS marker8, 10, 14, 15. To our knowledge, however, no study has yet reported full details regarding the expression of these antigens in rat ESS.

Here, to clarify the morphological and immunohistochemical features of rat ESS, we performed immunohistochemical analysis on the expression of a range of antigens, including vimentin, S-100, desmin, α-smooth muscle actin (αSMA), CD10, Iba1, ERα, and inhibin α. In addition, we assessed the utility of electron microscopic analysis in differential diagnosis of ESS from malignant schwannoma. Further, taking the findings into account, we reevaluated the diagnostic criteria of ESS.

Materials and Methods

Case selection and tissue preparation

The 12 cases used in this study had been diagnosed as ESS based on their histopathological features observed in HE-stained sections in previous two-year carcinogenicity studies. All cases were derived from control groups. All procedures were conducted with the permission of the institutional animal care and use committee at the facility.

The rat strains were as follows: Fischer344/DuCrlCrlj (F344) (n=7), Wistar Hannover (RccHanTM:WIST) (WH) (n=4), and Sprague Dawley (Crl:CD) (SD) (n=1). Tissues sampled at necropsy were fixed in 10% phosphate buffer formalin, embedded in paraffin, and serially sectioned at 4 μm. HE staining was performed according to the usual method for light microscopic examination. Sections of one tumor diagnosed as malignant schwannoma arising from a hepatodiaphragmatic nodule were used to compare with ESS.

Immunohistochemistry

Procedures for immunohistochemistry, including antibodies used as primary antibodies, are summarized in Table 1. Formalin-fixed and paraffin-embedded tissues were deparaffinized and rehydrated through graded alcohols. Endogenous peroxidase activity was quenched with 3% H2O2, followed by heat-induced antigen retrieval in a microwave at 95°C with citrate buffer at pH 6.0. After blocking endogenous peroxidase activity, sections were treated with serum-free protein block (Dako Japan, Tokyo, Japan) for 30 min at room temperature. Sections were then washed with washing buffer (Dako Japan, Tokyo, Japan) and reacted with the primary antibody overnight at 4°C. Sections were washed and treated by applying drops of Simple Stain Rat MAX PO (MUITI) (Nichirei Biosciences, Tokyo, Japan) to sections reacted with S-100, αSMA, CD10, Iba-1, and proliferating cell nuclear antigen (PCNA) primary antibodies for 10 min at room temperature or by applying drops of Simple Stain Mouse MAX-PO (G) (Nichirei Biosciences) to sections reacted with desmin for 30 min at room temperature. After washing sections with washing buffer, reactions were visualized using 3,3′-diaminobenzidine (DAB) as a chromogen. Sections were lightly counterstained with hematoxylin.

Table 1. Procedure and Primary Antibodies Used in Immunohistochemical Analysis.

graphic file with name tox-31-095-t001.jpg

Immunohistochemical evaluation

Immunohistochemically stained sections were semiquantitatively evaluated for the presence or absence of staining by light microscopy. The approximate rate of tumor cells showing positive reactions was classified into one of the following five grades: −, no cells positively stained in the tumor; ± , few (<1/4) cells positively stained in the tumor; +, some (<2/4) cells positively stained in the tumor; ++, many (<3/4) cells positively stained in the tumor; +++, most (>3/4) cells positively stained in the tumor.

Electron microscopy

Electron microscopy was performed on formalin-fixed tissues from Case 3 as pleomorphic/spindle cell and compact-type ESS, and Cases 10–12 as Antoni B-type schwannoma-type ESS; these cases were selected to examine if schwannoma-type and non-schwannoma-type ESSs have a basement membrane and desmosome-like structure. Tissues were cut into 1- to 2-mm3 cubes and washed in 0.1 M phosphate-buffered saline (PBS, pH 7.4) for 30 min, postfixed in 1% osmium tetroxide, and embedded in epoxy resin. Semithin sections (1 μm thick) were stained with 1% toluidine blue to select areas most appropriate for examination. Ultrathin sections were mounted on copper grids, stained with uranyl acetate and lead citrate, and examined using an H-7600 transmission electron microscope (Hitachi High-Tech Fielding Corporation, Tokyo, Japan).

Results

Histological and immunohistochemical evaluation

The 12 cases were classified into 6 types based on morphological characteristics, as follows: spindle cell and collagen-rich (CR) type (n=2), pleomorphic/spindle cell and compact (PC) type (n=3), decidual alteration (DA) type (n=1), histiocytic/multinucleated giant cell (HM) type (n=1), Antoni A-type schwannoma (SA) type (n=2), and Antoni B-type schwannoma (SB) type (n=3) (Fig. 1 and 2, Table 2).

Fig. 1.

Fig. 1.

Histological features of the CR, PC, DA, and HM types of ESS. (A, B) CR type, Case 2. Spindle tumor cells with round nuclei and abundant eosinophilic cytoplasm are visible in the collagenous stroma. (C, D) PC type, Case 3. Pleomorphic tumor cells with large nuclei are present compactly. (E, F) DA type, Case 6. Two different areas, (a) an epithelioid decidual cell proliferation area and (b) a spindle cell proliferation area, are recognizable. (G, H) HM type, Case 7. Two different areas, (a) a histiocytic sarcoma-like cell proliferation area and (b) a densely proliferated round nuclei tumor cell area, are distinctive. HE stain. Arrows = muscle layer; arrowheads = endometrial epithelium. Magnification: A, C, E, and G = 4×; B, D, F, and H = 40×.

Fig. 2.

Fig. 2.

Histological features of the SA and SB types of ESS. (A, B) SA type, Case 8. Spindle cells are arranged in an interlacing fasciculus with a nuclear palisading pattern. (C, D) SB type, Case 10. Spindle cells are sparsely proliferated with an edematous stroma, but there are no cystic structure in this field. (E, F) SB type, Case 11. Two different morphological areas, (a) an area with spindle cells forming cystic structure and (b) an area with spindle cells proliferating in interlacing fasciculi, are evident. (G, H) SB type, Case 12. Many cystic structures are present in this case. HE stain. Arrows = muscle layer; arrowhead = endometrial epithelium. Magnification: A, C, E, and G = 4×; B, D, F, and H = 40×.

Table 2. Summary of the Cases Examined, Immunohistochemistry, and Electron Microscopic Analysis.

graphic file with name tox-31-095-t002.jpg

CR type: Two cases were classified as the CR type (Cases 1 and 2). The histological features of the CR type were the proliferation of spindle tumor cells arranged in a loose sheet with abundant collagenous stroma. Tumor cells had round nuclei and abundant eosinophilic cytoplasm (Fig. 1B). Various sizes of blood vessels were frequently observed within the tumors (Fig. 1A and B). Cases 1 and 2 were positive on immunohistochemical analysis for vimentin, S-100, and either or both desmin or αSMA (Table 2, Fig. 3) and were positive for CD10 and ERα (Table 2). Only Case 2 was positive for inhibin α (Table 2). The CR type cases required a differential diagnosis from fibrosarcoma due to the morphological commonality between the two in terms of “abundant collagen”. However, CR-type cases expressed S-100, which is expressed on rat ESS but not expressed on fibrosarcoma, and either or both αSMA or desmin. Further, CR types also expressed ERα (expressed on rat endometrial stromal cells). Two CR type cases were therefore diagnosed as ESS.

Fig. 3.

Fig. 3.

Immunohistochemical images of cases from Figure 1. Top to bottom: CR type (Case 2), PC type (Case 3), DA type (Case 6), and HM type (Case 7). Left to right: S-100, desmin, αSMA, and ERα. Magnification: 40×.

PC type: Three cases were classified as the PC type (Cases 3–5). The morphological characteristics of the PC type were dense and solid proliferation of spindles to pleomorphic cells (Fig. 1C and D). Tumor cells had large nuclei and abundant cytoplasm with an indistinct cell border and some necrotic areas observed within the tumors. Cases 4 and 5 showed areas of tumor cells arranged in interlacing fasciculi. Cases 3–5 were immunohistochemically positive for vimentin and S-100 and any or all of αSMA, desmin, and ERα (Table 2, Fig. 3). Only Case 4 was positive for CD10 and inhibin α (Table 2). The PC-type cases required a differential diagnosis from leiomyosarcoma. However, the cases expressed S-100, and leiomyosarcoma was therefore excluded. The cases were therefore diagnosed as ESS.

DA type: One case was classified as the DA type (Case 6). Two areas with different morphological features were present within the tumor (Fig. 1E and F). Almost all areas of the tumor exhibited proliferation of epithelioid decidual cells (area a in Fig. 1E and F), and another area (area b in Fig 1E and F) exhibited proliferation of spindle to and pleomorphic cells. The area of spindle cell proliferation resembled the PC type. Translation between both areas was observed in the tumor. Both areas were positive on immunohistochemical analysis for vimentin, S-100, and desmin (Table 2, Fig. 3). In addition, both areas were positive for ERα and negative for CD10 and inhibin α (Table 2). Tumor cells of this type were derived from endometrial stromal cells, as the cells of origin of decidual reaction are uterine stromal cells and uterine metrial gland cells. The decidual reaction is sometimes associated with endometrial stromal polyp. The DA type was diagnosed as ESS due to mixed features of a decidual reaction and PC-type lesions and due to positive reaction for S-100 and ERα of the tumor cells.

HM type: One case was classified as the HM type (Case 7). Two areas with different morphological features were present within the tumor. In areas in the Fig. 1G and H, histiocytic sarcoma-like cells with an abundant pleomorphic cytoplasm and a round-to-wedge-shaped nucleus proliferated with multinucleated giant cells. In area b in Fig. 1G and H, tumor cells having abundant cytoplasm and round nuclear densely proliferated. In both areas, most tumor cells were positive on immunohistochemical analysis for vimentin and S-100, but tumor cells only in area a were positive for αSMA. Cells in both areas were positive for ERα and negative for Iba-1 (histiocyte marker), CD10, and inhibin α (Table 2). The HM type was morphologically similar to histiocytic sarcoma. However, the HM-type case examined in this study was completely negative for Iba1 and positive for αSMA, S-100, and ERα. The HM-type case was therefore diagnosed as ESS.

SA type: Two cases were classified as the SA type (Cases 8 and 9). Spindle tumor cells with an indistinct cell border arranged in an interlacing fasciculus and nuclear palisading pattern were observed, with substantial morphological similarity to schwannoma Antoni A (Fig. 2A and B). Case 8 was positive for vimentin and S-100, negative for muscle markers, and positive for ERα, CD10, and inhibin α (Table 2, Fig. 4). Case 9 was negative for all antigens except vimentin (Table 2, Fig. 4). The SA type was difficult to diagnose as ESS due to its morphological and immunohistochemical similarity to malignant schwannoma. However, Case 8 was diagnosed as ESS due to positivity for ERα, CD10, and inhibin α. Case 9 could not be distinctly diagnosed due to negative reactions in the immuhistochemical examination.

Fig. 4.

Fig. 4.

Immunohistochemical images of cases from Figure 2. Top to bottom: SA type (Case 8) and SB type (Cases 10–12). Left to right: S-100, desmin, αSMA, and ERα. Magnification: 40×.

SB type: Three cases were classified as the SB type (Cases 10–12). Spindle cells sparsely proliferated with an edematous stroma and formed cystic structures (Fig. 2C–H). The number of cystic structures in the tumors differed between the three cases: few structures were observed in Case 10, while many were observed in most areas of Case 12. In Case 11, two different morphological areas (areas a and b in Fig. 2E and F) were observed. In area a, spindle cells formed cystic structures, while in area b, spindle cells proliferated in interlacing fasciculi. All three cases were positive on immunohistochemical analysis for vimentin and S-100 (Table 2, Fig. 4). The reactivity for muscle markers was related to the presence of cystic structures. Areas without cystic structures in Cases 10 and 11 were positive for either desmin or αSMA, while areas with cystic structures in Cases 11 and 12 were only slightly positive or negative for these markers (Table 2, Fig. 4). All three cases were positive for ERα and negative for inhibin α, and Cases 10 and 11 were positive for CD10 (Table 2, Fig. 4). The SB type was also difficult to diagnose as ESS; however, cases 10 and 11 could be diagnosed as ESS, as they were positive for ERα and positive for muscle markers which suggested the same muscular marker manifestation potential as the CR, PC, DA, and HM types. Case 12 was assumed to be also ESS based on the positive reaction for ERα, but a distinct diagnose could not be made.

Of note, comparative sections diagnosed as malignant schwannoma arising from the hepatodiaphragmatic nodule were positive for S-100 and negative for ERα.

Electron microscopy

Electron microscopic analysis was performed in three SB-type cases and one PC-type case. A basement membrane was detected in tumor cells of all four cases, and a desmosome-like structure was also observed in one of the SB-type cases (Table 2, Fig. 5).

Fig. 5.

Fig. 5.

ESS with basement membrane. (A) SA type, Case 10. (B) PC type, Case 3. Arrows = basement membrane; arrowheads = desmosome-like structure. Scale bar = 1 μm.

Discussion

This study clarified the morphological and immunohistochemical features of rat ESS using human ESS markers. Our results demonstrated that most tumors protruding into the uterine lumen were derived from endometrial stromal cells. Additionally, the immunohistochemical results indicated that S-100 and ERα are effective immunohistochemical markers for identifying ESS in rats.

A number of reports have cited a positive reaction for S-100 in ESSs1, 2, 4, 5. S-100 is not expressed on normal endometrial stromal cells but is expressed on decidual cells of the placenta in pregnant rats16. S-100 might therefore be useful for differential diagnosis from leiomyosarcoma. Further, ERα is widely distributed throughout the uterus of healthy rats17; given that most cases in the present study reacted positively for ERα, the origin of these tumors might be uterine components. In addition, ERα is not expressed on Schwann cells of the peripheral nerve of the rat uterus or malignant schwannomas occurring in other tissues in rats. S-100 and ERα might therefore be useful in differentiating ESS from leiomyosarcoma and malignant schwannoma, respectively.

Positive reaction to S-100 and presence of a basement membrane in electron microscopy have been accepted as useful markers for diagnosis of malignant schwannoma. However, based on the following findings the positive expression of S-100 in most ESSs and basement membrane surrounding tumor cells in several ESSs, indicated the both markers are not sufficient or useful to determine that tumor cells originated from schwann cells. A previous study reported that ESSs have the potential to produce a basement membrane and desmosome-like structures, because human endometrial stromal cells producing basement protein laminin around cells during the secretory phase18. Another also reported that stromal cells have the potential to produce a basement membrane and desmosome-like structures in rabbit deciduosarcoma19. ESS is considered to have potential to form a basement membrane and desmosome-like structure due to endometrial stromal cells having the ability to differentiate to decidual cells.

The conventional criteria for immunohistochemical reaction in rat ESS state that muscle markers such as desmin and actin are negative in rat ESSs1, 2, 4, 5. In human ESSs, a positive reaction for muscular markers in immunohistochemical reactions indicate that ESS tumor cells have differentiated to smooth muscle8, 10, 20. In a previous report about endometrial stromal sarcoma emphasizing fibroblastic and smooth muscle differentiation, Yilmans et al. thought that the presence of even focal endometrial stromal differentiation in an invasive uterine mesenchymal lesion with a predominant low-grade smooth muscle, fibroblastic, and/or myxoid phenotype should permit classification as low-grade sarcoma and that the lesions should be considered endometrial stromal sarcomas11. Similar results in almost cases in the present study, particularly in the area of spindle cells arranged in interlacing fasciculi resembling muscle tumors, suggest a variation of ESS with smooth muscle differentiation. A positive reaction for muscle markers might not be definitive for crucially distinguishing ESS from leiomyosarcoma.

While CD10, an established marker of ESS in humans8, 9, 10 is expressed on human endometrial stromal cells, it is not expressed on normal rat endometrial stromal cells21. Although positive results for this marker in 5 of the 12 cases were obtained in the present study, CD10 is not considered to be an effective marker for diagnosing rat ESS.

We concluded that almost all cases of the six types of uterine malignant tumor protruding into the lumen observed in this study were ESS. While differentiation of ESS from other sarcomas can be difficult due to its varying morphological features, the generalization that tumors should be diagnosed based on their cellular origin suggests that most uterine sarcomas protruding into the lumen may be diagnosed as ESSs, regardless of the morphological features and degree of differentiation. However, in cases in which a tumor is similar to other sarcomas, immunohistochemical analysis may be necessary to obtain a correct diagnosis.

Disclosure of Potential Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

We would like to thank Ms. Chie Shiroumaru, Ms. Masayo Onozawa, Ms. Misako Morino, Ms. Kiyoe Otobe, Ms. Miki Kudo, and Ms. Keika Kinoshita for their technical support.

References

  • 1.Dixon D, Leininger JR, Valerio MG, Johnson AN, Stabinski LG, and Frith CH. Proliferative lesions of the ovary, uterus, bagina, cervix and oviduct in rats. In: Guides for Toxicologic Pathology. STP/ARP/AFIP, Washington, DC. 1999. [Google Scholar]
  • 2.Dixon D, Alison R, Bach U, Colman K, Foley GL, Harleman JH, Haworth R, Herbert R, Heuser A, Long G, Mirsky M, Regan K, Van Esch E, Westwood FR, Vidal J, and Yoshida M. Nonproliferative and proliferative lesions of the rat and mouse female reproductive system. J Toxicol Pathol. 27(Suppl): 1S–107S. 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Goodman DG, and Hildebrandt PK. Stromal sarcoma, endometrium, rat: Neoplasms. In: Monographs on Pathology of Laboratory Animals, Genital System. TC Jones, U Mohr, and RD Hunt (eds). Springer-Verlag, Berlin. 70–72. 1987. [Google Scholar]
  • 4.Greaves P. Decidua, decidual reactionl deciduoma, epithelial plaque; Storomal sarcoma; uterus. In: Histopathology of Preclinical Toxicity Studies, 4th ed. P Greaves (ed). Academic Press, San Diego. 677–689. 2012. [Google Scholar]
  • 5.Leininger JR, and Jokinen MP. Malignant schwannoma; Uterus; Hyperplastic and neoplastic lesions; Oviduct, uterus and vasina. In: Pathology of the Fischer Rat: Reference and Atlas. GA Boorman, SL Eustis, MR Elwell, CA Montgomery Jr., and WF MacKenzie (eds). Academic Press. San Diego. 455. 1990. [Google Scholar]
  • 6.Maita K, Hirano M, Harada T, Mitsumori K, Yoshida A, Takahashi K, Nakashima N, Kitazawa T, Enomoto A, Inui K, and Shirasu Y. Spontaneous tumors in F344/DuCrj rats from 12 control groups of chronic and oncogenicity studies. J Toxicol Sci. 12: 111–126. 1987. [DOI] [PubMed] [Google Scholar]
  • 7.Amant F, Moerman P, Cadron I, Neven P, Berteloot P, and Vergote I. The diagnostic problem of endometrial stromal sarcoma: report on six cases. Gynecol Oncol. 90: 37–43. 2003. [DOI] [PubMed] [Google Scholar]
  • 8.Chu PG, Arber DA, Weiss LM, and Chang KL. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol. 14: 465–471. 2001. [DOI] [PubMed] [Google Scholar]
  • 9.McCluggage WG, Sumathi VP, and Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology. 39: 273–278. 2001. [DOI] [PubMed] [Google Scholar]
  • 10.Xue WC, and Cheung AN. Endometrial stromal sarcoma of uterus. Best Pract Res Clin Obstet Gynaecol. 25: 719–732. 2011. [DOI] [PubMed] [Google Scholar]
  • 11.Yilmaz A, Rush DS, and Soslow RA. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation. Am J Surg Pathol. 26: 1142–1150. 2002. [DOI] [PubMed] [Google Scholar]
  • 12.Greaves MF, Brown G, Rapson NT, and Lister TA. Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol. 4: 67–84. 1975. [DOI] [PubMed] [Google Scholar]
  • 13.Greaves MF, Hariri G, Newman RA, Sutherland DR, Ritter MA, and Ritz J. Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. Blood. 61: 628–639. 1983. [PubMed] [Google Scholar]
  • 14.Park JY, Sung CO, Jang SJ, Song SY, Han JH, and Kim KR. Pulmonary metastatic nodules of uterine low-grade endometrial stromal sarcoma: histopathological and immunohistochemical analysis of 10 cases. Histopathology. 63: 833–840. 2013. [DOI] [PubMed] [Google Scholar]
  • 15.Zhu XQ, Shi YF, Cheng XD, Zhao CL, and Wu YZ. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma. Gynecol Oncol. 92: 71–79. 2004. [DOI] [PubMed] [Google Scholar]
  • 16.Picut CA, Swanson CL, Parker RF, Scully KL, and Parker GA. The metrial gland in the rat and its similarities to granular cell tumors. Toxicol Pathol. 37: 474–480. 2009. [DOI] [PubMed] [Google Scholar]
  • 17.Nephew KP, Long X, Osborne E, Burke KA, Ahluwalia A, and Bigsby RM. Effect of estradiol on estrogen receptor expression in rat uterine cell types. Biol Reprod. 62: 168–177. 2000. [DOI] [PubMed] [Google Scholar]
  • 18.Faber M, Wewer UM, Berthelsen JG, Liotta LA, and Albrechtsen R. Laminin production by human endometrial stromal cells relates to the cyclic and pathologic state of the endometrium. Am J Pathol. 124: 384–391. 1986. [PMC free article] [PubMed] [Google Scholar]
  • 19.Bernard CZ. Deciduosarcomas in rabbits induced by a combination of estrogen and progestin: Oviducts/uterus. In: Monographs on Pathology of Laboratory Animals, Genital System. TC Jones, U Mohr, and RD Hunt (eds.). Springer-Verlag, Berlin. 72–78. 1987. [Google Scholar]
  • 20.Kim YH, Cho H, Kyeom-Kim H, and Kim I. Uterine endometrial stromal sarcoma with rhabdoid and smooth muscle differentiation. J Korean Med Sci. 11: 88–93. 1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Yoshizawa K, Emoto Y, Kinoshita Y, Kimura A, Uehara N, Yuri T, Shikata N, and Tsubura A. Histopathological and immunohistochemical characterization of spontaneously occurring uterine deciduomas in young adult rats. J Toxicol Pathol. 26: 61–66. 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Toxicologic Pathology are provided here courtesy of The Japanese Society of Toxicologic Pathology

RESOURCES